Microscopically positive margins for primary gastrointestinal stromal tumors: Analysis of risk factors and tumor recurrence Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Gastrointestinal Stromal Tumors
  • Neoplasm Recurrence, Local
  • Piperazines
  • Pyrimidines

abstract

  • Approximately 9% of 819 GIST patients had an R1 resection. Significant factors associated with R1 resection include tumor size ≥ 10 cm, location, and rupture. The difference in recurrence-free survival with or without imatinib therapy in those undergoing an R1 vs R0 resection was not statistically significant at a median follow-up of 4 years.

publication date

  • July 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3383609

Digital Object Identifier (DOI)

  • 10.1016/j.jamcollsurg.2012.05.008

PubMed ID

  • 22726733

Additional Document Info

start page

  • 53

end page

  • 9; discussion 59-60

volume

  • 215

number

  • 1